Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NETRIS Pharma, Orano and CLB partner to develop new radio-conjugates
NETRIS Pharma, Orano and CLB will initially conduct a preclinical study with the new radio-conjugate targeting Netrin-1. Credit: National Cancer Institute on Unsplash.
NETRIS Pharma, Orano and CLB will initially conduct a preclinical study with the new radio-conjugate targeting Netrin-1. Credit: National Cancer Institute on Unsplash.